CelLBxHealth secures USD65,000 pharmaceutical research contract

Racura Oncology receives approval for RC220 trial to proceed to higher dose

Foresee gains NMPA approval for CAMCEVI 42 mg in China

ABL Texcell Diagnostics acquires IntegraGen assets to expand into precision oncology

Perceptive Discovery partners with Nucleus RadioPharma Inc to accelerate radiopharmaceutical development

Akeso reports first patient dosed in Phase III study of cadonilimab in colon cancer

Natera secures FDA Breakthrough Device designation for multi-cancer early detection assay

FDA approves Genentech's Tecentriq combination therapy for stage III colon cancer

Alpheus Medical starts new clinical trial of PoMA therapy in butterfly glioblastoma

Sophos IRB and ALCMI partner to support lung cancer research

Northwest Biotherapeutics and NHSBT collaborate to support production of DCVax-L

Vir Biotechnology's VIR-5500 receives FDA Fast Track designation for prostate cancer

Voyager signs cancer research mission management contract

AstraZeneca completes USD2bn equity investment in Summit Therapeutics

GE HealthCare to acquire SOFIE Biosciences for USD945m